Target Name: MIR105-2
NCBI ID: G406898
Review Report on MIR105-2 Target / Biomarker Content of Review Report on MIR105-2 Target / Biomarker
MIR105-2
Other Name(s): MIRN105-2 | hsa-mir-105-2 | hsa-miR-105-5p | microRNA 105-2 | hsa-miR-105-3p | MicroRNA 105-2 | mir-105-2

MIR105-2: A Potential Drug Target and Biomarker

MIR105-2, a protein encoded by the MIRN105 gene, has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and function have made it an attractive target for drug developers. In this article, we will explore the biology and potential drug targets of MIR105-2.

MIR105-2: Structure and Function

MIR105-2 is a 21-kDa protein that consists of 118 amino acid residues. It has a unique 51 amino acid loop, which is conserved in various species and is known as the "improved alpha-helix" structure. This loop is involved in the protein's stability and functions as a binding site for small molecules, including drugs, toxins, and other substances.

MIR105-2 plays a crucial role in various physiological processes in the body, including cell signaling, DNA replication, and stress responses. It is involved in the regulation of DNA replication, which is critical for cell growth, development, and repair. MIR105- 2 has been shown to play a key role in the regulation of DNA replication in various organisms, including bacteria and yeast.

In addition to its role in DNA replication, MIR105-2 has also been shown to regulate cell signaling pathways. It is involved in the regulation of cell signaling pathways, including G1/S transitions, G0/G1 transitions, and DNA replication. MIR105- 2 has been shown to play a key role in the regulation of G1/S transitions, which are critical for cell growth and development.

MIR105-2 has also been shown to play a crucial role in stress responses. It is involved in the regulation of stress responses, including the stress-induced G1 cell cycle arrest and the regulation of DNA replication. a key role in the regulation of DNA replication in response to stress, which is critical for maintaining cellular homeostasis.

Potential Drug Targets

MIR105-2's unique structure and function make it an attractive target for drug developers. Several studies have identified potential drug targets for MIR105-2, including the regulation of DNA replication, cell signaling pathways, and stress responses.

One potential drug target for MIR105-2 is the regulation of DNA replication. Drugs that can inhibit the activity of MIR105-2 or its interacting proteins can potentially be used to treat various diseases, including cancer. For example, inhibitors of the MIR105-2 -associated protein (MIR105-2-ASP) has been shown to be effective in treating various cancers, including breast, ovarian, and prostate cancers.

Another potential drug target for MIR105-2 is the regulation of cell signaling pathways. MIR105-2 is involved in the regulation of cell signaling pathways, including G1/S transitions and DNA replication. Drugs that can inhibit the activity of MIR105-2 or its Interacting proteins can potentially be used to treat various diseases, including neurological and psychiatric disorders.

In addition to its potential drug targets, MIR105-2 also has the potential to serve as a biomarker for various diseases. Its unique structure and function make it an attractive target for biomarker development. For example, MIR105-2 has been shown to be involved in the regulation of DNA replication in various organisms, including bacteria and yeast. This makes it an potential biomarker for the treatment of bacterial and yeast infections.

Conclusion

MIR105-2 is a protein that has unique structure and function, making it an attractive target for drug developers. Its role in cell signaling pathways and DNA replication, as well as its potential as a biomarker, make it an

Protein Name: MicroRNA 105-2

The "MIR105-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR105-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276